Literature DB >> 24238845

Expression and significance of notch signaling pathway in salivary adenoid cystic carcinoma.

Diana Bell1, Ehab Y Hanna, Lucio Miele, Dianna Roberts, Randal S Weber, Adel K El-Naggar.   

Abstract

Notch signaling plays a role in stem cell biology, tumor formation, angiogenesis, and cell death. Targeting Notch pathway could serve as a therapeutic strategy in cancer. Little is known about the differential role of various components of the Notch pathway in salivary adenoid cystic carcinoma (AdCC). To investigate the association of the Notch pathway in AdCC carcinogenesis, we analyzed the Notch receptor (Notch-1, Notch-2, Notch-4) and Notch ligand (Jagged-1, Delta) expressions. The results showed elevated expression levels of all 5 proteins in AdCC tissue relative to normal salivary gland tissues. Jagged-1/Notch-2 coexpression was significantly associated with increased patient survival rate. The elevated expression level of these Notch receptors and ligands in AdCC points to Notch signaling as a key player in AdCC pathogenesis. Our data provide evidence for a relationship between Jagged-1/Notch-2 coexpression and better overall patient survival with AdCC. Targeting Notch signaling pathway may provide therapeutic benefits for these patients.
© 2013.

Entities:  

Keywords:  AdCC; Adenoid cystic; CSC; Cancer stem cells; Carcinoma; Notch; Notch-2/Jagged-1; Targeted therapy; adenoid cystic carcinoma; cancer stem cells

Mesh:

Substances:

Year:  2013        PMID: 24238845      PMCID: PMC4807115          DOI: 10.1016/j.anndiagpath.2013.10.001

Source DB:  PubMed          Journal:  Ann Diagn Pathol        ISSN: 1092-9134            Impact factor:   2.090


  23 in total

1.  Intraoral salivary gland neoplasms: a retrospective study of seventy cases in an African population.

Authors:  W F van Heerden; E J Raubenheimer
Journal:  Oral Surg Oral Med Oral Pathol       Date:  1991-05

Review 2.  Systemic therapy in the palliative management of advanced salivary gland cancers.

Authors:  Scott A Laurie; Lisa Licitra
Journal:  J Clin Oncol       Date:  2006-06-10       Impact factor: 44.544

3.  Phase II clinical trial data with the epidermal growth factor receptor tyrosine kinase inhibitor erlotinib (OSI-774) in non-small-cell lung cancer.

Authors:  Roman Perez-Soler
Journal:  Clin Lung Cancer       Date:  2004-12       Impact factor: 4.785

4.  Expression of the c-kit receptor characterizes a subset of neuroblastomas with favorable prognosis.

Authors:  Matthias Krams; Reza Parwaresch; Bence Sipos; Klaus Heidorn; Dieter Harms; Pierre Rudolph
Journal:  Oncogene       Date:  2004-01-15       Impact factor: 9.867

5.  [Malignant epithelial salivary gland tumors. Clinical review of 2 decades].

Authors:  H Kokemüller; N Brüggemann; P Brachvogel; A Eckardt
Journal:  Mund Kiefer Gesichtschir       Date:  2004-02-07

6.  Cancer stem cells: an old idea--a paradigm shift.

Authors:  Max S Wicha; Suling Liu; Gabriela Dontu
Journal:  Cancer Res       Date:  2006-02-15       Impact factor: 12.701

Review 7.  Breast cancer, stem/progenitor cells and the estrogen receptor.

Authors:  Gabriela Dontu; Dorraya El-Ashry; Max S Wicha
Journal:  Trends Endocrinol Metab       Date:  2004-07       Impact factor: 12.015

8.  Epithelial malignancies of the salivary glands: clinical experience of a single institution-a review.

Authors:  H Kokemueller; G Swennen; N Brueggemann; P Brachvogel; A Eckardt; J-E Hausamen
Journal:  Int J Oral Maxillofac Surg       Date:  2004-07       Impact factor: 2.789

9.  Phase II trial of taxol in salivary gland malignancies (E1394): a trial of the Eastern Cooperative Oncology Group.

Authors:  Jill Gilbert; Yi Li; Harlan A Pinto; Timothy Jennings; Merrill S Kies; Paula Silverman; Arlene A Forastiere
Journal:  Head Neck       Date:  2006-03       Impact factor: 3.147

Review 10.  Myoepithelial cells: autocrine and paracrine suppressors of breast cancer progression.

Authors:  Sanford H Barsky; Nina J Karlin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-07       Impact factor: 2.698

View more
  15 in total

Review 1.  Head and Neck Carcinoma Immunotherapy: Facts and Hopes.

Authors:  Theresa L Whiteside
Journal:  Clin Cancer Res       Date:  2017-07-27       Impact factor: 12.531

2.  Notch signaling induces epithelial-mesenchymal transition to promote invasion and metastasis in adenoid cystic carcinoma.

Authors:  Zhi-Li Zhao; Si-Rui Ma; Wei-Ming Wang; Cong-Fa Huang; Guang-Tao Yu; Tian-Fu Wu; Lin-Lin Bu; Yu-Fan Wang; Yi-Fang Zhao; Wen-Feng Zhang; Zhi-Jun Sun
Journal:  Am J Transl Res       Date:  2015-01-15       Impact factor: 4.060

3.  Overexpression of DCLK1 is predictive for recurrent disease in major salivary gland malignancies.

Authors:  Lorenz Kadletz; Klaus Aumayr; Gregor Heiduschka; Sven Schneider; Elisabeth Enzenhofer; Claudia Lill
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-07-28       Impact factor: 2.503

Review 4.  Notch signaling in oral pre-cancer and oral cancer.

Authors:  Kumud Nigam; Ratnesh Kumar Srivastav
Journal:  Med Oncol       Date:  2021-10-11       Impact factor: 3.064

5.  Notch-1 knockdown suppresses proliferation, migration and metastasis of salivary adenoid cystic carcinoma cells.

Authors:  Wei Chen; Gang Cao; Xinran Yuan; Xiang Zhang; Qingqing Zhang; Yinglan Zhu; Zhen Dong; Senlin Zhang
Journal:  J Transl Med       Date:  2015-05-20       Impact factor: 5.531

6.  Fatty Acid binding protein 7 is a molecular marker in adenoid cystic carcinoma of the salivary glands: implications for clinical significance.

Authors:  Janyaporn Phuchareon; Jonathan B Overdevest; Frank McCormick; David W Eisele; Annemieke van Zante; Osamu Tetsu
Journal:  Transl Oncol       Date:  2014-12       Impact factor: 4.243

7.  The role of eukaryotic translation initiation factor 6 in tumors.

Authors:  Wei Zhu; Gui Xian Li; Hong Lang Chen; Xing Yan Liu
Journal:  Oncol Lett       Date:  2017-05-12       Impact factor: 2.967

8.  Activating NOTCH1 Mutations Define a Distinct Subgroup of Patients With Adenoid Cystic Carcinoma Who Have Poor Prognosis, Propensity to Bone and Liver Metastasis, and Potential Responsiveness to Notch1 Inhibitors.

Authors:  Renata Ferrarotto; Yoshitsugu Mitani; Lixia Diao; Irene Guijarro; Jing Wang; Patrick Zweidler-McKay; Diana Bell; William N William; Bonnie S Glisson; Michael J Wick; Ann M Kapoun; Amita Patnaik; Gail Eckhardt; Pamela Munster; Leonardo Faoro; Jakob Dupont; J Jack Lee; Andrew Futreal; Adel K El-Naggar; John V Heymach
Journal:  J Clin Oncol       Date:  2016-11-21       Impact factor: 44.544

9.  The Prognostic Significance of Notch1 and Fatty Acid Binding Protein 7 (FABP7) Expression in Resected Tracheobronchial Adenoid Cystic Carcinoma: A Multicenter Retrospective Study.

Authors:  Mian Xie; Xiaojun Wu; Jinjun Zhang; Chaosheng He; Shenhai Wei; Junyao Huang; Xinge Fu; Yingying Gu
Journal:  Cancer Res Treat       Date:  2017-11-15       Impact factor: 4.679

Review 10.  Adenoid cystic carcinoma: A review of recent advances, molecular targets, and clinical trials.

Authors:  Patrick M Dillon; Samhita Chakraborty; Christopher A Moskaluk; Prashant J Joshi; Christopher Y Thomas
Journal:  Head Neck       Date:  2015-06-16       Impact factor: 3.147

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.